Search results for "Inflammatory bowel disease"
Machine learning model predicted mortality among malnourished inpatients with IBD
Integrating such models into clinical practice could improve identification of inflammatory bowel disease (IBD) patients at risk for malnutrition and potentially reduce their mortality by prompting earlier intervention, according to the authors of a new study.
https://gastroenterology.acponline.org/archives/2025/02/28/3.htm
28 Feb 2025
Risk for herpes zoster complications appears higher with IBD
A retrospective cohort study found that herpes zoster complications occurred in 15.52% of patients with inflammatory bowel disease (IBD) who got the virus versus 12.51% of those without IBD, a statistically significant difference.
https://gastroenterology.acponline.org/archives/2024/11/22/2.htm
22 Nov 2024
Spotlight on IBD therapy comparisons
Recent research on inflammatory bowel disease (IBD) therapies compared vedolizumab with anti-tumor necrosis factor therapy, risankizumab with ustekinumab for Crohn's disease, and upadacitinib with tofacitinib for ulcerative colitis.
https://gastroenterology.acponline.org/archives/2024/07/26/5.htm
26 Jul 2024
Colectomy linked with greater risk of AKI, kidney failure in patients with IBD
Among patients with inflammatory bowel disease (IBD), colectomy was linked with more than doubled risk of acute kidney injury (AKI), indicating that these patients may benefit from close monitoring of kidney biomarkers, according to the authors of a Swedish cohort study.
https://gastroenterology.acponline.org/archives/2024/05/24/3.htm
24 May 2024
Review finds antibiotics associated with heightened risk of inflammatory bowel disease
There was a positive, nonlinear dose-response association between the number of antibiotic prescriptions patients received and their inflammatory bowel disease risk, according to a systematic review.
https://gastroenterology.acponline.org/archives/2024/03/22/2.htm
22 Mar 2024
AGA issues guidance on diet, nutrition in IBD
A new clinical practice update from the American Gastroenterological Association (AGA) covers the role of diet and nutritional therapies in managing inflammatory bowel disease (IBD) and identifying and treating malnutrition in IBD patients.
https://gastroenterology.acponline.org/archives/2024/02/23/1.htm
23 Feb 2024
IBD patients may be at higher risk for CKD
A Swedish study found that 11.8% of patients with inflammatory bowel disease (IBD) were diagnosed with chronic kidney disease (CKD) within 10 years, and their risks of acute kidney injury and kidney stones were also elevated.
https://gastroenterology.acponline.org/archives/2023/08/25/2.htm
25 Aug 2023
IBD increases long-term stroke risk, study finds
A Swedish study found that patients with inflammatory bowel disease (IBD) were at higher risk for incident stroke, especially ischemic stroke, versus matched controls and versus their siblings for up to 25 years.
https://gastroenterology.acponline.org/archives/2023/06/23/3.htm
23 Jun 2023
Healthy lifestyle may mitigate genetic risk for inflammatory bowel disease
In a cohort study, U.K. residents with high genetic risk for inflammatory bowel disease who met four or five lifestyle measures developed Crohn's disease or ulcerative colitis at higher-than-average rates, but at about half the rate of those with both genetic risk and an unhealthy lifestyle.
https://gastroenterology.acponline.org/archives/2023/01/27/3.htm
27 Jan 2023
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022
Spotlight on surgical management of IBD
One recent study found that Black patients are at increased risk of morbidity after surgery for inflammatory bowel disease (IBD), while another found benefit of early surgery after diagnosis in certain patients.
https://gastroenterology.acponline.org/archives/2022/10/28/5.htm
28 Oct 2022
IV iron regimens compared for serum phosphate effects in patients with IBD
Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.
https://gastroenterology.acponline.org/archives/2022/09/23/2.htm
23 Sep 2022
Infliximab or tofacitinib for IBD associated with lower response to COVID-19 vaccination
An industry-funded study in England looked at SARS-CoV-2 antibody concentrations after two vaccine doses among patients taking infliximab, tofacitinib, thiopurine, ustekinumab, or vedolizumab for inflammatory bowel disease (IBD), comparing them to healthy controls.
https://gastroenterology.acponline.org/archives/2022/02/25/1.htm
25 Feb 2022
Spotlight on COVID-19 vaccines in IBD
Recent research looked at the response to mRNA COVID-19 vaccines among patients with inflammatory bowel disease (IBD), as well as examined COVID-19 vaccine uptake and offered ways to address vaccine hesitancy in this population.
https://gastroenterology.acponline.org/archives/2021/10/22/5.htm
22 Oct 2021
Guidance offered for managing colorectal dysplasia in patients with IBD
Among other best practice advice from the American Gastroenterological Association, precancerous colorectal lesions in patients with inflammatory bowel disease (IBD) should be described as polypoid, nonpolypoid, or invisible using a modified Paris Classification.
https://gastroenterology.acponline.org/archives/2021/09/24/1.htm
24 Sep 2021
Patients with IBD who catch COVID-19 have high clot risk, study finds
Infection with SARS-CoV-2 was associated with an eightfold increase in the risk of venous thromboembolism among patients with inflammatory bowel disease (IBD), but the risk was mitigated by chronic anticoagulation, according to a retrospective study.
https://gastroenterology.acponline.org/archives/2021/06/25/1.htm
25 Jun 2021
Spotlight on IBD therapy effects
Research in the past month found that infliximab blunts the body's immune response to COVID-19 infection, that both infliximab and adalimumab are effective in long-term treatment of outpatients with inflammatory bowel disease (IBD), and that antitumor necrosis factor therapy may be associated with reduced mortality compared with long-term corticosteroid use in patients with Crohn's disease.
https://gastroenterology.acponline.org/archives/2021/03/26/5.htm
26 Mar 2021
Spotlight on colorectal neoplasia in IBD
Recent research focused on colorectal neoplasia in patients with inflammatory bowel disease (IBD), identifying both risk factors, including a novel association with cigarette smoke exposure, and protective factors.
https://gastroenterology.acponline.org/archives/2021/01/22/5.htm
22 Jan 2021
Cannabis, cannabinoids didn't improve remission or inflammatory markers in IBD
A meta-analysis of inflammatory bowel disease (IBD) studies did find improvements in patient-reported symptoms and quality of life associated with cannabis and cannabinoids.
https://gastroenterology.acponline.org/archives/2020/07/24/3.htm
24 Jul 2020
Inflammatory bowel disease associated with higher risk for dementia
Patients with inflammatory bowel disease were diagnosed with dementia an average of seven years earlier than matched controls in a Taiwanese study.
https://gastroenterology.acponline.org/archives/2020/06/26/2.htm
26 Jun 2020